Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
letter
. 1969 Aug 16;3(5667):394–396. doi: 10.1136/bmj.3.5667.394

Inhibition by Aspirin of Release of Antiheparin Activity from Human Platelets

A H Youssef, P Barkhan
PMCID: PMC1984151  PMID: 5797782

Abstract

Both in vitro and in vivo, aspirin inhibited the adenosine diphosphate and collagen-induced release of platelet factor 4 (antiheparin factor). The release induced by adrenaline and thrombin was not affected. The in-vivo effect in normal persons lasted for at least three days. Platelet uptake of acetyl-14C-aspirin was significantly greater than that of carboxyl-14C-aspirin.

Full text

PDF
394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUHLER D. R. A simple scintillation counting technique for assaying C1402 in a Warburg flask. Anal Biochem. 1962 Nov;4:413–417. doi: 10.1016/0003-2697(62)90143-4. [DOI] [PubMed] [Google Scholar]
  2. Barkhan P., Youssef A. Effect of salicylates on human platelets. Lancet. 1968 Aug 10;2(7563):359–359. doi: 10.1016/s0140-6736(68)90579-5. [DOI] [PubMed] [Google Scholar]
  3. Evans G., Packham M. A., Nishizawa E. E., Mustard J. F., Murphy E. A. The effect of acetylsalicyclic acid on platelet function. J Exp Med. 1968 Nov 1;128(5):877–894. doi: 10.1084/jem.128.5.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Farbiszewski R., Lipiński B., Niewiarowski S., Poplawski A. Hypercoagulability and thrombocytopenia after platelet factor 4infusion into rabbits. Experientia. 1968 Jun 15;24(6):578–579. doi: 10.1007/BF02153783. [DOI] [PubMed] [Google Scholar]
  5. Niewiarowski S., Farbiszewski R., Poplawski A. Neutralization of antithrombin VI (fibrinogen breakdown products) with platelet antiheparin factor (platelet factor 4). Thromb Diath Haemorrh. 1965 Nov 15;14(3-4):490–499. [PubMed] [Google Scholar]
  6. Niewiarowski S., Lipiński B., Farbiszewski R., Poplawski A. The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis. Experientia. 1968 Apr 15;24(4):343–344. doi: 10.1007/BF02140810. [DOI] [PubMed] [Google Scholar]
  7. O'Brien J. R. Effect of anti-inflammatory agents on platelets. Lancet. 1968 Apr 27;1(7548):894–895. doi: 10.1016/s0140-6736(68)90242-0. [DOI] [PubMed] [Google Scholar]
  8. O'Brien J. R. Effects of salicylates on human platelets. Lancet. 1968 Apr 13;1(7546):779–783. doi: 10.1016/s0140-6736(68)92228-9. [DOI] [PubMed] [Google Scholar]
  9. Pinckard R. N., Hawkins D., Farr R. S. In vitro acetylation of plasma proteins, enzymes and DNA by aspirin. Nature. 1968 Jul 6;219(5149):68–69. doi: 10.1038/219068a0. [DOI] [PubMed] [Google Scholar]
  10. Weiss H. J., Aledort L. M. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967 Sep 2;2(7514):495–497. doi: 10.1016/s0140-6736(67)91658-3. [DOI] [PubMed] [Google Scholar]
  11. Weiss H. J., Aledort L. M., Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest. 1968 Sep;47(9):2169–2180. doi: 10.1172/JCI105903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Youssef A., Barkhan P. Release of platelet factor 4 by adenosine diphosphate and other platelet-aggregating agents. Br Med J. 1968 Mar 23;1(5594):746–747. doi: 10.1136/bmj.1.5594.746. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES